ARTICLE | Company News
AlphaRx drug delivery, autoimmune news
December 5, 2011 8:00 AM UTC
AlphaRx said it will shift the primary focus of the company to digital marketing in China. The company's Indaflex missed the primary endpoints in a Phase II trial to treat osteoarthritis in 2007. Indaflex is a topical cream formulation of indomethacin (see BioCentury, May 21, 2007). ...